Srinivas Akkaraju Insider Profile

11 Followers
Srinivas Akkaraju, Director at ZS Pharma, holds 6.80M shares in Scholar Rock Holding (Ticker: SRRK), holds 1.70M shares in Alumis Inc. (Ticker: ALMS), holds 6.67K shares in Syros Pharmaceuticals (Ticker: SYRS).
tipranks
Srinivas Akkaraju

Srinivas Akkaraju
ZS Pharma (ZSPH)
Director

Ranked #88,601 out of 98,123 Corporate Insiders

Profitable Transactions

35%
8 out of 23 Profitable Transactions

Average Return

-16.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$151M
42.12%
41.46%
13.52%
2.88%
0.03% Others
A breakdown of Srinivas Akkaraju's holdings

Insider Roles

Mineralys Therapeutics, Inc.
(MLYS)
Director, Ten Percent Owner
Scholar Rock Holding
(SRRK)
Director
Alumis Inc.
(ALMS)
Director
vTv Therapeutics
(VTVT)
Director, Ten Percent Owner
+1 other positions
Roles that Srinivas Akkaraju holds in companies

Most Profitable Insider Trade

Stock:
Chinook Therapeutics
(KDNY)
Rating:Informative Buy
Date:Aug 20, 2021 - Aug 20, 2022
Return:+71.30%
The most profitable trade made by Srinivas Akkaraju

Srinivas Akkaraju's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ZSPH
ZS Pharma
Dec 21, 2015
Uninformative Sell
90.00K
$0.00
Syros Pharmaceuticals
Jun 04, 2024
Director
Uninformative Buy
20.40K
$41.73K
PRNB
Principia Biopharma
Sep 20, 2018
Informative Buy
2.98M
$38.37M
KDNY
Chinook Therapeutics
Aug 11, 2023
Uninformative Sell
$0.00
JYAC
Jiya Acquisition
Scholar Rock Holding
Jul 01, 2024
Director
Uninformative Buy
$62.44M
Mineralys Therapeutics, Inc.
Feb 14, 2024
Director, Ten Percent Owner
Uninformative Buy
7.50M
$63.44M
vTv Therapeutics
Feb 29, 2024
Director, Ten Percent Owner
Uninformative Buy
2.65M
$4.33M
Alumis Inc.
Jul 01, 2024
Director
Uninformative Buy
$20.36M
ARAV
Aravive
Dec 02, 2019
Informative Buy
1000.00K
$24.32K
ICPT
Intercept Pharma
May 25, 2023
Uninformative Buy
$13.05M
SGEN
Seagen
May 19, 2020
Uninformative Buy
$9.49M
GEVA
Synageva
Jun 28, 2012
Informative Sell
13.60M
List of latest transactions for each holding click on a transaction to see Srinivas Akkaraju's performance on stock

Srinivas Akkaraju insider profile FAQ

What is the percentage of profitable transactions made by Srinivas Akkaraju?
The percentage of profitable transactions made by Srinivas Akkaraju is 35%.
    What is the average return per transaction made by Srinivas Akkaraju?
    The average return per transaction made by Srinivas Akkaraju is -16.40%.
      What stocks does Srinivas Akkaraju hold?
      Srinivas Akkaraju holds: ZSPH, SYRS, PRNB, KDNY, JYAC, SRRK, MLYS, VTVT, ALMS, ARAV, ICPT, SGEN, GEVA stocks.
        What was Srinivas Akkaraju’s latest transaction?
        Srinivas Akkaraju latest transaction was an Uninformative Buy of ―.
          What was Srinivas Akkaraju's most profitable transaction?
          Srinivas Akkaraju’s most profitable transaction was an Informative Buy of KDNY stock on August 20, 2021. The return on the trade was 71.30%.
            What is Srinivas Akkaraju's role in ZS Pharma?
            Srinivas Akkaraju's role in ZS Pharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.